Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.

BACKGROUND:The complications of Nonalcoholic Fatty Liver Disease (NAFLD) are dependent on the presence of advanced fibrosis. Given the high prevalence of NAFLD in the US, the optimal evaluation of NAFLD likely involves triage by a primary care physician (PCP) with advanced disease managed by gastroe...

Full description

Bibliographic Details
Main Authors: Elliot B Tapper, M G Myriam Hunink, Nezam H Afdhal, Michelle Lai, Neil Sengupta
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4764354?pdf=render
id doaj-118e6e6bacce4763aa7e80cb9363e724
record_format Article
spelling doaj-118e6e6bacce4763aa7e80cb9363e7242020-11-25T01:28:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01112e014723710.1371/journal.pone.0147237Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.Elliot B TapperM G Myriam HuninkNezam H AfdhalMichelle LaiNeil SenguptaBACKGROUND:The complications of Nonalcoholic Fatty Liver Disease (NAFLD) are dependent on the presence of advanced fibrosis. Given the high prevalence of NAFLD in the US, the optimal evaluation of NAFLD likely involves triage by a primary care physician (PCP) with advanced disease managed by gastroenterologists. METHODS:We compared the cost-effectiveness of fibrosis risk-assessment strategies in a cohort of 10,000 simulated American patients with NAFLD performed in either PCP or referral clinics using a decision analytical microsimulation state-transition model. The strategies included use of vibration-controlled transient elastography (VCTE), the NAFLD fibrosis score (NFS), combination testing with NFS and VCTE, and liver biopsy (usual care by a specialist only). NFS and VCTE performance was obtained from a prospective cohort of 164 patients with NAFLD. Outcomes included cost per quality adjusted life year (QALY) and correct classification of fibrosis. RESULTS:Risk-stratification by the PCP using the NFS alone costs $5,985 per QALY while usual care costs $7,229/QALY. In the microsimulation, at a willingness-to-pay threshold of $100,000, the NFS alone in PCP clinic was the most cost-effective strategy in 94.2% of samples, followed by combination NFS/VCTE in the PCP clinic (5.6%) and usual care in 0.2%. The NFS based strategies yield the best biopsy-correct classification ratios (3.5) while the NFS/VCTE and usual care strategies yield more correct-classifications of advanced fibrosis at the cost of 3 and 37 additional biopsies per classification. CONCLUSION:Risk-stratification of patients with NAFLD primary care clinic is a cost-effective strategy that should be formally explored in clinical practice.http://europepmc.org/articles/PMC4764354?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Elliot B Tapper
M G Myriam Hunink
Nezam H Afdhal
Michelle Lai
Neil Sengupta
spellingShingle Elliot B Tapper
M G Myriam Hunink
Nezam H Afdhal
Michelle Lai
Neil Sengupta
Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
PLoS ONE
author_facet Elliot B Tapper
M G Myriam Hunink
Nezam H Afdhal
Michelle Lai
Neil Sengupta
author_sort Elliot B Tapper
title Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
title_short Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
title_full Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
title_fullStr Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
title_full_unstemmed Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
title_sort cost-effectiveness analysis: risk stratification of nonalcoholic fatty liver disease (nafld) by the primary care physician using the nafld fibrosis score.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description BACKGROUND:The complications of Nonalcoholic Fatty Liver Disease (NAFLD) are dependent on the presence of advanced fibrosis. Given the high prevalence of NAFLD in the US, the optimal evaluation of NAFLD likely involves triage by a primary care physician (PCP) with advanced disease managed by gastroenterologists. METHODS:We compared the cost-effectiveness of fibrosis risk-assessment strategies in a cohort of 10,000 simulated American patients with NAFLD performed in either PCP or referral clinics using a decision analytical microsimulation state-transition model. The strategies included use of vibration-controlled transient elastography (VCTE), the NAFLD fibrosis score (NFS), combination testing with NFS and VCTE, and liver biopsy (usual care by a specialist only). NFS and VCTE performance was obtained from a prospective cohort of 164 patients with NAFLD. Outcomes included cost per quality adjusted life year (QALY) and correct classification of fibrosis. RESULTS:Risk-stratification by the PCP using the NFS alone costs $5,985 per QALY while usual care costs $7,229/QALY. In the microsimulation, at a willingness-to-pay threshold of $100,000, the NFS alone in PCP clinic was the most cost-effective strategy in 94.2% of samples, followed by combination NFS/VCTE in the PCP clinic (5.6%) and usual care in 0.2%. The NFS based strategies yield the best biopsy-correct classification ratios (3.5) while the NFS/VCTE and usual care strategies yield more correct-classifications of advanced fibrosis at the cost of 3 and 37 additional biopsies per classification. CONCLUSION:Risk-stratification of patients with NAFLD primary care clinic is a cost-effective strategy that should be formally explored in clinical practice.
url http://europepmc.org/articles/PMC4764354?pdf=render
work_keys_str_mv AT elliotbtapper costeffectivenessanalysisriskstratificationofnonalcoholicfattyliverdiseasenafldbytheprimarycarephysicianusingthenafldfibrosisscore
AT mgmyriamhunink costeffectivenessanalysisriskstratificationofnonalcoholicfattyliverdiseasenafldbytheprimarycarephysicianusingthenafldfibrosisscore
AT nezamhafdhal costeffectivenessanalysisriskstratificationofnonalcoholicfattyliverdiseasenafldbytheprimarycarephysicianusingthenafldfibrosisscore
AT michellelai costeffectivenessanalysisriskstratificationofnonalcoholicfattyliverdiseasenafldbytheprimarycarephysicianusingthenafldfibrosisscore
AT neilsengupta costeffectivenessanalysisriskstratificationofnonalcoholicfattyliverdiseasenafldbytheprimarycarephysicianusingthenafldfibrosisscore
_version_ 1725102437401886720